This project explores how the gut microbiome and its metabolic products influence host physiology, particularly glucose regulation, satiety, and lipid metabolism. Using literature and data-driven tools, the goal is to identify specific microbial pathways or metabolites that could serve as novel therapeutic entry points, either via microbial engineering, metabolite supplementation, or microbiota modulation (e.g. pre/pro/postbiotics).

For pharmaceutical or biotech companies aiming to expand their metabolic pipelines, microbiome-based interventions represent an exciting frontier. This project supports first-in-class thinking, innovation scouting, and early-stage exploratory R&D. It also opens possibilities for partnerships in the nutrition, diagnostics, or digital health space.

The gut–brain–metabolism axis is such an elegant system, and I find the idea of designing treatments that don’t directly target the human body, but rather its microbial symbionts, endlessly exciting. This project allows me to combine immunology, metabolic biology, and data-driven thinking, all areas I am passionate about.

You’d be getting a scientifically curious, highly motivated student with a strong background in immunology, microbiology, and systems thinking. I thrive in interdisciplinary projects, bring structure and drive to the table, and am not afraid to push into new areas with a learning mindset. I'm confident in navigating complexity and committed to delivering quality.